News Agencies Feed

healthcare

Oct 18

Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products

Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products

Concept Medical B.V. with its headquarters in Tampa, Florida has announced that on 16th October 2019, they have received the CE certification for their MagicTouch group of products. The CE certified products/brands are as listed below: MagicTouch – PTA (Sirolimus Coated PTA Balloon Catheter) for peripheral arterial disease MagicTouch – ED (Sirolimus Coated Balloon Catheter) for Erectile Dysfunction MagicTouch – AVF (Sirolimus Coated PTA Balloon Catheter) for Arterio-Venous Fistula and Graft MagicTouch – PTA is the only commercially available and CE certified Sirolimus coated balloon catheter for peripheral arterial......

Continue Reading >>

Oct 17

How Saudi Arabia is leading Middle East’s fight against breast cancer

How Saudi Arabia is leading Middle East’s fight against breast cancer

ABU DHABI: Cancer of the breast remains the most common form of the disease among women despite major advances in treatment coupled with improved screening and awareness campaigns.

Rates of the disease are increasing"...

Continue Reading >>

Oct 17

Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation Host Pandemic Exercise and Livestream

Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation Host Pandemic Exercise and Livestream

The Johns Hopkins Center for Health Security, with the World Economic Forum and the Bill & Melinda Gates Foundation, will host Event 201, a multimedia global pandemic exercise on Friday, Oct. 18, 2019, in New York City. The public may register and participate in the simultaneous virtual exercise in English, 8:50 a.m.-12:30 p.m. EDT at centerforhealthsecurity.org/event201/. The exercise underscores the need for global public-private cooperation to mitigate economic and societal impacts of severe pandemics. In recent years, the world......

Continue Reading >>

Oct 16

Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CFTM 1)

Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CFTM 1)

Boehringer Ingelheim today announced the first patient enrolled in its Phase II clinical trial BALANCE-CFTM 1 to evaluate a new potential treatment for cystic fibrosis.1,2 The trial will investigate how different doses of the compound, an inhaled epithelial sodium channel (ENaC) inhibitor,"...

Continue Reading >>

Oct 16

Accomplishments of Dr. Steven Rosenberg in Cancer Immunotherapy Inspire Young Researchers in Japan & XIV Fujio Cup Quiz on Stem Cells Is Won by India.

Accomplishments of Dr. Steven Rosenberg in Cancer Immunotherapy Inspire Young Researchers in Japan & XIV Fujio Cup Quiz on Stem Cells Is Won by India.

Utilizing the capability of one’s own immune system to tackle cancer, an out-of-the box idea was the brain child of Dr. Steven Rosenberg almost three decades ago. His initiative which paved way for a new chapter in oncology, inspired many young scientists and clinicians in the NCRM"...

Continue Reading >>

Oct 15

Homes gutted by huge forest fires in Lebanon’s Shouf mountains

Homes gutted by huge forest fires in Lebanon’s Shouf mountains

DUBAI: Homes were gutted by huge forest fires that have ripped through the Shouf mountains in the center of the country, the Lebanese civil defense said on Tuesday.

A special needs center run by non-profit organization"...

Continue Reading >>

Oct 15

Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USD

Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USD

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa (NEMEA) countries"...

Continue Reading >>

Oct 14

Analysis of Patients With Prior Gastrectomy Treated With LONSURF® (trifluridine/tipiracil) Published in JAMA Oncology

Analysis of Patients With Prior Gastrectomy Treated With LONSURF® (trifluridine/tipiracil) Published in JAMA Oncology

Servier and its partner Taiho Oncology, Inc. (US), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today that detailed results from the analysis of patients with prior gastrectomy enrolled in the Phase III TAS-102 Gastric Study (TAGS) evaluating LONSURF® (trifluridine/tipiracil)"...

Continue Reading >>

Oct 13

$800 million invested in hospital expansions

$800 million invested in hospital expansions

More than 1,000 beds, as well as many operating rooms and intensive care units, will be added to hospitals in next few years.

Established hospitals have allocated around $700 million to expand their premises, and improve the quality of their services, according to the October"...

Continue Reading >>

Oct 13

Fakih IVF Supports Breast Cancer Awareness Month

Fakih IVF Supports Breast Cancer Awareness Month

In support of the Breast Cancer Awareness Month, Fakih IVF Fertility Center seeks to reach out to all women battling the disease by helping preserve their fertility and fulfill their dream of starting a family.

Throughout"...

Continue Reading >>